1 Acromegaly Drugs Market Overview 1.1 Product Overview and Scope of Acromegaly Drugs 1.2 Acromegaly Drugs Segment by Type 1.2.1 Global Acromegaly Drugs Sales Growth Rate Comparison by Type (2020-2026) 1.2.2 Octreotide 1.2.3 Pasireotide 1.2.4 Lanreotide 1.2.5 Pegvisomant 1.3 Acromegaly Drugs Segment by Application 1.3.1 Acromegaly Drugs Sales Comparison by Application: (2020-2026) 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Global Acromegaly Drugs Market Size Estimates and Forecasts 1.4.1 Global Acromegaly Drugs Revenue 2015-2026 1.4.2 Global Acromegaly Drugs Sales 2015-2026 1.4.3 Acromegaly Drugs Market Size by Region: 2020 Versus 2026 2 Global Acromegaly Drugs Market Competition by Manufacturers 2.1 Global Acromegaly Drugs Sales Market Share by Manufacturers (2015-2020) 2.2 Global Acromegaly Drugs Revenue Share by Manufacturers (2015-2020) 2.3 Global Acromegaly Drugs Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Acromegaly Drugs Manufacturing Sites, Area Served, Product Type 2.5 Acromegaly Drugs Market Competitive Situation and Trends 2.5.1 Acromegaly Drugs Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Acromegaly Drugs Players (Opinion Leaders) 3 Acromegaly Drugs Retrospective Market Scenario by Region 3.1 Global Acromegaly Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Acromegaly Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Acromegaly Drugs Market Facts & Figures by Country 3.3.1 North America Acromegaly Drugs Sales by Country 3.3.2 North America Acromegaly Drugs Sales by Country 3.3.3 the United States 3.3.4 Canada 3.4 Europe Acromegaly Drugs Market Facts & Figures by Country 3.4.1 Europe Acromegaly Drugs Sales by Country 3.4.2 Europe Acromegaly Drugs Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 UK 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Acromegaly Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Acromegaly Drugs Sales by Region 3.5.2 Asia Pacific Acromegaly Drugs Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Acromegaly Drugs Market Facts & Figures by Country 3.6.1 Latin America Acromegaly Drugs Sales by Country 3.6.2 Latin America Acromegaly Drugs Sales by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Acromegaly Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Acromegaly Drugs Sales by Country 3.7.2 Middle East and Africa Acromegaly Drugs Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Acromegaly Drugs Historic Market Analysis by Type 4.1 Global Acromegaly Drugs Sales Market Share by Type (2015-2020) 4.2 Global Acromegaly Drugs Revenue Market Share by Type (2015-2020) 4.3 Global Acromegaly Drugs Price Market Share by Type (2015-2020) 4.4 Global Acromegaly Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Acromegaly Drugs Historic Market Analysis by Application 5.1 Global Acromegaly Drugs Sales Market Share by Application (2015-2020) 5.2 Global Acromegaly Drugs Revenue Market Share by Application (2015-2020) 5.3 Global Acromegaly Drugs Price by Application (2015-2020) 6 Company Profiles and Key Figures in Acromegaly Drugs Business 6.1 Novartis 6.1.1 Corporation Information 6.1.2 Novartis Description, Business Overview 6.1.3 Novartis Acromegaly Drugs Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Novartis Products Offered 6.1.5 Novartis Recent Development 6.2 IPSEN 6.2.1 IPSEN Corporation Information 6.2.2 IPSEN Description, Business Overview 6.2.3 IPSEN Acromegaly Drugs Sales, Revenue and Gross Margin (2015-2020) 6.2.4 IPSEN Products Offered 6.2.5 IPSEN Recent Development 6.3 Pfizer 6.3.1 Pfizer Corporation Information 6.3.2 Pfizer Description, Business Overview 6.3.3 Pfizer Acromegaly Drugs Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Pfizer Products Offered 6.3.5 Pfizer Recent Development 7 Acromegaly Drugs Manufacturing Cost Analysis 7.1 Acromegaly Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Acromegaly Drugs 7.4 Acromegaly Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Acromegaly Drugs Distributors List 8.3 Acromegaly Drugs Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Acromegaly Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Acromegaly Drugs by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Acromegaly Drugs by Type (2021-2026) 10.2 Acromegaly Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Acromegaly Drugs by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Acromegaly Drugs by Application (2021-2026) 10.3 Acromegaly Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Acromegaly Drugs by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Acromegaly Drugs by Region (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Acromegaly Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Acromegaly Drugs Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Acromegaly Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Acromegaly Drugs Manufacturers Covered in This Study Table 5. Global Acromegaly Drugs Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Acromegaly Drugs Sales Share by Manufacturers (2015-2020) Table 7. Global Acromegaly Drugs Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Acromegaly Drugs Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Acromegaly Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Acromegaly Drugs Sales Sites and Area Served Table 11. Manufacturers Acromegaly Drugs Product Types Table 12. Global Acromegaly Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Acromegaly Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acromegaly Drugs as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Acromegaly Drugs Players Table 16. Global Acromegaly Drugs Sales (K Units) by Region (2015-2020) Table 17. Global Acromegaly Drugs Sales Market Share by Region (2015-2020) Table 18. Global Acromegaly Drugs Revenue (Million US$) by Region (2015-2020) Table 19. Global Acromegaly Drugs Revenue Market Share by Region (2015-2020) Table 20. North America Acromegaly Drugs Sales by Country (2015-2020) (K Units) Table 21. North America Acromegaly Drugs Sales Market Share by Country (2015-2020) Table 22. North America Acromegaly Drugs Revenue by Country (2015-2020) (US$ Million) Table 23. North America Acromegaly Drugs Revenue Market Share by Country (2015-2020) Table 24. Europe Acromegaly Drugs Sales by Country (2015-2020) (K Units) Table 25. Europe Acromegaly Drugs Sales Market Share by Country (2015-2020) Table 26. Europe Acromegaly Drugs Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Acromegaly Drugs Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Acromegaly Drugs Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Acromegaly Drugs Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Acromegaly Drugs Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Acromegaly Drugs Revenue Market Share by Region (2015-2020) Table 32. Latin America Acromegaly Drugs Sales by Country (2015-2020) (K Units) Table 33. Latin America Acromegaly Drugs Sales Market Share by Country (2015-2020) Table 34. Latin America Acromegaly Drugs Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Acromegaly Drugs Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Acromegaly Drugs Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Acromegaly Drugs Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Acromegaly Drugs Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Acromegaly Drugs Revenue Market Share by Country (2015-2020) Table 40. Global Acromegaly Drugs Sales (K Units) by Type (2015-2020) Table 41. Global Acromegaly Drugs Sales Share by Type (2015-2020) Table 42. Global Acromegaly Drugs Revenue (Million US$) by Type (2015-2020) Table 43. Global Acromegaly Drugs Revenue Share by Type (2015-2020) Table 44. Global Acromegaly Drugs Price (USD/Unit) by Type (2015-2020) Table 45. Global Acromegaly Drugs Sales (K Units) by Application (2015-2020) Table 46. Global Acromegaly Drugs Sales Market Share by Application (2015-2020) Table 47. Global Acromegaly Drugs Sales Growth Rate by Application (2015-2020) Table 48. Novartis Corporation Information Table 49. Novartis Description and Business Overview Table 50. Novartis Acromegaly Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Novartis Main Product Table 52. Novartis Recent Development Table 53. IPSEN Corporation Information Table 54. IPSEN Description and Business Overview Table 55. IPSEN Acromegaly Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. IPSEN Main Product Table 57. IPSEN Recent Development Table 58. Pfizer Corporation Information Table 59. Pfizer Description and Business Overview Table 60. Pfizer Acromegaly Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Pfizer Main Product Table 62. Pfizer Recent Development Table 63. Production Base and Market Concentration Rate of Raw Material Table 64. Key Suppliers of Raw Materials Table 65. Acromegaly Drugs Distributors List Table 66. Acromegaly Drugs Customers List Table 67. Acromegaly Drugs Market Trends Table 68. Acromegaly Drugs Opportunities and Drivers Table 69. Acromegaly Drugs Market Challenges Table 70. Global Acromegaly Drugs Sales (K Units) Forecast by Type (2021-2026) Table 71. Global Acromegaly Drugs Sales Market Share Forecast by Type (2021-2026) Table 72. Global Acromegaly Drugs Revenue (Million US$) Forecast by Type (2021-2026) Table 73. Global Acromegaly Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 74. Global Acromegaly Drugs Sales (K Units) Forecast by Application (2021-2026) Table 75. Global Acromegaly Drugs Revenue (Million US$) Forecast by Application (2021-2026) Table 76. Global Acromegaly Drugs Sales (K Units) Forecast by Region (2021-2026) Table 77. Global Acromegaly Drugs Sales Market Share Forecast by Region (2021-2026) Table 78. Global Acromegaly Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 79. Global Acromegaly Drugs Revenue Market Share Forecast by Region (2021-2026) Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Acromegaly Drugs Figure 2. Global Acromegaly Drugs Sales Market Share by Type: 2020 VS 2026 Figure 3. Octreotide Product Picture Figure 4. Pasireotide Product Picture Figure 5. Lanreotide Product Picture Figure 6. Pegvisomant Product Picture Figure 7. Global Acromegaly Drugs Consumption Market Share by Application: 2020 VS 2026 Figure 8. Hospital Figure 9. Pharmacy Figure 10. Global Acromegaly Drugs Market Size 2015-2026 (US$ Million) Figure 11. Global Acromegaly Drugs Sales Capacity (K Units) (2015-2026) Figure 12. Global Acromegaly Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Acromegaly Drugs Sales Share by Manufacturers in 2020 Figure 14. Global Acromegaly Drugs Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Acromegaly Drugs Revenue in 2019 Figure 16. Acromegaly Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Acromegaly Drugs Sales Market Share by Region (2015-2020) Figure 18. Global Acromegaly Drugs Sales Market Share by Region in 2019 Figure 19. Global Acromegaly Drugs Revenue Market Share by Region (2015-2020) Figure 20. Global Acromegaly Drugs Revenue Market Share by Region in 2019 Figure 21. North America Acromegaly Drugs Sales Market Share by Country in 2019 Figure 22. North America Acromegaly Drugs Revenue Market Share by Country in 2019 Figure 23. the United States Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 24. the United States Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 26. Canada Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Acromegaly Drugs Sales Market Share by Country in 2019 Figure 28. Europe Acromegaly Drugs Revenue Market Share by Country in 2019 Figure 29. Germany Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 30. Germany Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 32. France Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. UK Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 34. UK Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 36. Italy Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 38. Russia Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Acromegaly Drugs Sales Market Share by Region in 2019 Figure 40. Asia Pacific Acromegaly Drugs Revenue Market Share by Region in 2019 Figure 41. China Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 42. China Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 44. Japan Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 46. South Korea Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 48. India Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. Australia Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. Taiwan Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 54. Indonesia Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. Thailand Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 58. Malaysia Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 60. Philippines Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 62. Vietnam Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Acromegaly Drugs Sales Market Share by Country in 2019 Figure 64. Latin America Acromegaly Drugs Revenue Market Share by Country in 2019 Figure 65. Mexico Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. Mexico Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. Brazil Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 70. Argentina Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Acromegaly Drugs Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Acromegaly Drugs Revenue Market Share by Country in 2019 Figure 73. Turkey Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Turkey Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. Saudi Arabia Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. UAE Acromegaly Drugs Sales Growth Rate (2015-2020) (K Units) Figure 78. UAE Acromegaly Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Acromegaly Drugs by Type (2015-2020) Figure 80. Sales Market Share of Acromegaly Drugs by Type in 2020 Figure 81. Global Acromegaly Drugs Market Share by Price Range (2015-2020) Figure 82. Revenue Market Share of Acromegaly Drugs by Type in 2019 Figure 83. Global Acromegaly Drugs Sales Growth by Type (2015-2020) (K Units) Figure 84. Sales Market Share of Acromegaly Drugs by Application (2015-2020) Figure 85. Sales Market Share of Acromegaly Drugs by Application in 2020 Figure 86. Revenue Share of Acromegaly Drugs by Application (2015-2020) Figure 87. Revenue Share of Acromegaly Drugs by Application in 2020 Figure 88. Key Raw Materials Price Trend Figure 89. Manufacturing Cost Structure of Acromegaly Drugs Figure 90. Manufacturing Process Analysis of Acromegaly Drugs Figure 91. Acromegaly Drugs Industrial Chain Analysis Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Porter's Five Forces Analysis Figure 95. Bottom-up and Top-down Approaches for This Report Figure 96. Data Triangulation Figure 97. Key Executives Interviewed

Novartis IPSEN Pfizer